Form 8-K · Current report
DuPont 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0001666700
- Accession no.
- 0001666700-26-000049
Summary
DuPont reported second-quarter 2026 results with net sales of $1.8 billion, up 4% organically, GAAP income from continuing operations of $191 million and adjusted EPS of $1.88, exceeding its guidance, and raised its full-year 2026 outlook for operating EBITDA and adjusted EPS. CEO Lori Koch attributed the quarter to mid-single-digit organic growth and margin expansion, and CFO Antonella Franzen cited strength in healthcare, industrial water and aerospace end-markets, with the company also announcing intent to repurchase $250 million of shares in the third quarter.
Key points
- Second-quarter 2026 net sales were $1,819 million, up 4% versus the year-ago period on 4% organic growth.
- Operating EBITDA rose 6% to $448 million with a 24.6% margin; adjusted EPS rose 48% to $1.88.
- Full-year 2026 guidance was raised to net sales of $7.16–7.19 billion, operating EBITDA of $1.75–1.77 billion and adjusted EPS of $7.17–7.32.
- DuPont announced its GICS code changed to Industrials effective July 31, 2026, following the Aramids divestiture to Arclin and the November 2025 separation of Qnity Electronics.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On August 4, 2026, DuPont de Nemours, Inc. (the "Company") issued a press release, attached as Exhibit 99.1, and incorporated herein by reference, announcing results for the second quarter 2026. The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of Section 18. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.